Release Date: 02/08/13 09:50 Summary: Anticipated Impairment of Osborne Copper-Gold Asset Price Sensitive: Yes Download Document 174.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%